All In MedTech

Device Trial Radar · NCT02626208

Dose Finding Study of Contraceptive Vaginal Ring With Different Estradiol Levels in Combination With Nestorone

A Dose Finding Study to Evaluate Serum Estradiol Levels With Use of Contraceptive Vaginal Rings Releasing Nestorone® and Escalating Doses of Estradiol in Normal Cycling Women

Last checked: Nov 19, 2026Latest source record: Aug 15, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

65

Actual

Start

Jan 2016

Primary completion

Mar 2017

Study completion Mar 2017

Sponsor

Lead sponsor
Premier ResearchAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Population Council; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
First posted
Dec 10, 2015

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Prevention
Who can join
Female only, from 18 years, up to 39 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This clinical trial investigates a new vaginal delivery system made of silicone rubber, containing Nestorone®, a 19-nor progesterone derivative and a low dose of serum estradiol (E2). The investigators plan to evaluate one-month data on the serum estradiol (E2) levels of three different contraceptive vaginal rings that contain a fixed dose of NES and escalating doses (75 µg/day, 100 µg/day, or 200 µg/day) of estradiol as the basis for selecting a CVR for a larger contraceptive efficacy trial.

Conditions

  • Suppression of Ovulation

Interventions

  • Nestorone®/Estradiol Contraceptive Vaginal RingDevice

    Three arms of contraceptive vaginal rings contain a fixed dose (200 mcg/day) of Nestorone® and escalating doses (75 µg/d, 100 µg/d, or 200 µg/d /day) of estradiol

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in serum estradiol (E2) levels of three different contraceptive vaginal ringsTime frame: Assessments will be taken before insertion of the study ring (Day 1); Day 4 or ; Twice weekly during study ring use (approximately Days 7 or 8, 11 or 12, 14 or 15, 18 or 19, 21 or 22, 25 or 26) and at removal of study ring (Day 28-30)

Locations

7 sites in 1 country. Site status is shown where the registry gives one.

  • University of California, Davis

    Sacramento, California

  • Columbia University

    New York, New York

  • University of Cincinnati

    Cincinnati, Ohio

4 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.